<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The effect of <z:chebi fb="5" ids="28304">heparin</z:chebi> and the synthetic irreversible antithrombin <z:chebi fb="0" ids="29996,32500">D-phenylalanyl</z:chebi>-<z:chebi fb="0" ids="32865">L-prolyl</z:chebi>-<z:chebi fb="0" ids="29952,32684">L-arginyl</z:chebi> chloromethyl <z:chebi fb="3" ids="17087">ketone</z:chebi> (FPRCH2Cl) was studied on <z:chebi fb="0" ids="30808">FeCl3</z:chebi>-induced thrombotic occlusion of rat carotid arteries </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0001873'>Thrombocytopenia</z:hpo> prevented occlusion in five of 7 rats for the 60 min observation period after <z:chebi fb="0" ids="30808">FeCl3</z:chebi> injury demonstrating platelet dependence in this model of <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Intravenous injection of <z:chebi fb="5" ids="28304">heparin</z:chebi> (250 units/kg) followed by continuous infusion (250 units/kg/hr) failed to prevent occlusion in four of 6 rats whereas intravenous FPRCH2Cl infusion prevented occlusion at a dose of 200 nmol/kg/min during infusion in 6/6 rats </plain></SENT>
<SENT sid="3" pm="."><plain>These findings indicate that thrombin plays a principle role in the platelet-dependent process of <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> in <z:chebi fb="0" ids="30808">FeCl3</z:chebi>-damaged rat carotid arteries </plain></SENT>
<SENT sid="4" pm="."><plain>Neutralization of the thrombogenic stimulus in this model by the thrombin inhibitor FPRCH2Cl suggests selective thrombin inhibition may be useful in the treatment of <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> </plain></SENT>
</text></document>